Drug Type Small molecule drug |
Synonyms AE-116 |
Target |
Mechanism mTORC1 inhibitors(Mammalian target of Rapamycin (mTORC1) inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Preclinical | US | - | |
Central Nervous System Diseases | Preclinical | US | - |